DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Swisher EM, Lin KK, Oza AM. et al.
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.
Lancet Oncol 2017;
18: 75-87
We do not assume any responsibility for the contents of the web pages of other providers.